NCT04341727: A reported trial by Washington University School of Medicine
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04341727 |
|---|---|
| Title | Open-label, Randomized Controlled Trial of Hydroxychloroquine, Hydroxychloroquine Plus Azithromycin, Chloroquine Alone, Chloroquine Plus Azithromycin in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infection |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 4, 2020 |
| Completion date | April 1, 2021 |
| Required reporting date | April 1, 2022, midnight |
| Actual reporting date | Feb. 4, 2022 |
| Date last checked at ClinicalTrials.gov | May 30, 2025 |
| Days late | None |